Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Rivulet Media, Inc.Financial_Report.xls
10-Q - QUARTERLY REPORT - Rivulet Media, Inc.bmsn_10qv.htm
EX-32.2 - CERTIFICATION - Rivulet Media, Inc.bmsn_ex322.htm
EX-31.1 - CERTIFICATION - Rivulet Media, Inc.bmsn_ex311.htm
EX-10.1 - CONVERTIBLE PROMISSORY NOTE - Rivulet Media, Inc.bmsn_ex101.htm
EX-32.1 - CERTIFICATION - Rivulet Media, Inc.bmsn_ex321.htm

 

Exhibit 31.2



CERTIFICATION OF ACTING CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, David Koos, Chief Financial Officer of Bio-Matrix Scientific Group, Inc. (Registrant) certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Registrant.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4.  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the Registrants internal control over financial reporting that occurred during the Registrants most recent fiscal quarter (the Registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrants internal control over financial reporting; and

 

5.  I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrants auditors and the audit committee of Registrants board of directors (or persons performing the equivalent function):

 

(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; and

 

(b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting

 

Date:  April 23, 2012

 

By:   /s/ David R. Koos

Acting Chief Financial Officer